WallStSmart
PRLD

Prelude Therapeutics Inc

NASDAQ: PRLD · HEALTHCARE · BIOTECHNOLOGY

$4.14
+6.70% today

Updated 2026-10-28

Market cap
$289.69M
P/E ratio
—
P/S ratio
12.92x
EPS (TTM)
$-0.72
Dividend yield
—
52W range
$1 – $7
Volume
0.5M

Prelude Therapeutics Inc (PRLD) Insider transactions

Net insider activity
Net buying (22,438,657 shares)
Buy transactions
82
Sell transactions
18

All transactions

DateInsiderTitleTypeSharesPriceValue
2026-06-09SANDOR, VICTORDirectorBuy38,000——
2026-06-09FRIEDMAN, PAUL ADirectorBuy38,000——
2026-06-09DORTON, KATINADirectorBuy38,000——
2026-06-09BONITA, DAVID PDirector, 10% OwnerBuy38,000——
2026-06-09BAKER, BROS. ADVISORS LPDirector, 10% OwnerBuy38,000——
2026-06-09BABLER, MARTINDirectorBuy38,000——
2026-05-01MORRIS, CHARLES QChief Medical OfficerBuy450,000$4.70$2.12M
2026-04-27RA, CAPITAL MANAGEMENT, L.P.10% OwnerBuy1,407,000——
2026-04-27RA, CAPITAL MANAGEMENT, L.P.10% OwnerSale1,407,000——
2026-04-21ORBIMED, ADVISORS LLCDirector, 10% OwnerBuy1,689,189$4.44$7.50M
2026-04-21ORBIMED, ADVISORS LLCDirector, 10% OwnerBuy1,126,126$4.44$5.00M
2026-04-21BONITA, DAVID PDirector, 10% OwnerBuy1,689,189$4.44$7.50M
2026-04-21BONITA, DAVID PDirector, 10% OwnerBuy1,126,126$4.44$5.00M
2026-04-21BAKER, BROS. ADVISORS LPDirector, 10% OwnerBuy2,137,651$4.44$9.49M
2026-04-21BAKER, BROS. ADVISORS LPDirector, 10% OwnerBuy114,601$4.44$508816.98
2026-02-04VADDI, KRISHNADirector, CEOBuy837,000——
2026-02-04SCHERLE, PEGGYChief Scientific OfficerBuy230,000——
2026-02-04LIM, BRYANT DAVIDCLO, CFO, Corp Sec.Buy275,000——
2026-02-04COMBS, ANDREWChief Chemistry OfficerBuy230,000——
2025-11-05SANDOR, VICTORDirectorBuy121,285——
2025-10-17DORTON, KATINADirectorBuy76,000——
2025-10-04HUANG, JANEPresident, CMOSale9,375——
2025-10-04HUANG, JANEPresident, CMOBuy9,375——
2025-10-04HUANG, JANEPresident, CMOSale3,355$1.47$4931.85
2025-07-04HUANG, JANEPresident, CMOSale9,375——
2025-07-04HUANG, JANEPresident, CMOBuy9,375——
2025-07-04HUANG, JANEPresident, CMOSale3,355$0.79$2663.53
2025-06-12SANDOR, VICTORDirectorBuy38,000——
2025-06-12FRIEDMAN, PAUL ADirectorBuy38,000——
2025-06-12DIER, MARDIDirectorBuy38,000——
2025-06-12BONITA, DAVID PDirector, 10% OwnerBuy38,000——
2025-06-12BAKER, BROS. ADVISORS LPDirector, 10% OwnerBuy76,000——
2025-06-12BABLER, MARTINDirectorBuy38,000——
2025-04-04HUANG, JANEPresident, CMOSale9,375——
2025-04-04HUANG, JANEPresident, CMOBuy9,375——
2025-04-04HUANG, JANEPresident, CMOSale3,355$0.68$2264.63
2025-03-25VADDI, KRISHNADirector, CEOBuy675,000$0.69$467437.50
2025-03-25COMBS, ANDREWChief Chemistry OfficerBuy100,000$0.69$69250.00
2025-03-21VADDI, KRISHNADirector, CEOBuy15,000$0.73$10959.00
2025-03-20VADDI, KRISHNADirector, CEOBuy5,416$0.73$3950.43
2025-03-17VADDI, KRISHNADirector, CEOBuy9,106$0.75$6828.59
2025-03-14VADDI, KRISHNADirector, CEOBuy29,999$0.75$22631.25
2025-03-13VADDI, KRISHNADirector, CEOBuy50,000$0.72$35820.00
2025-03-12VADDI, KRISHNADirector, CEOBuy47,500$0.71$33744.00
2025-02-04VADDI, KRISHNADirector, CEOBuy496,000——
2025-02-04SCHERLE, PEGGYChief Scientific OfficerBuy175,000——
2025-02-04LIM, BRYANT DAVIDCLO, CFO, Corp Sec.Buy200,000——
2025-02-04HUANG, JANEPresident, CMOBuy200,000——
2025-02-04COMBS, ANDREWChief Chemistry OfficerBuy175,000——
2025-01-04HUANG, JANEPresident, CMOBuy9,375——
2025-01-04HUANG, JANEPresident, CMOBuy9,375——
2025-01-04HUANG, JANEPresident, CMOSale3,859$1.39$5364.01
2024-12-31VADDI, KRISHNADirector, CEOBuy5,000$1.21$6043.50
2024-12-30VADDI, KRISHNADirector, CEOBuy10,000$1.20$12000.00
2024-12-23COMBS, ANDREWChief Chemistry OfficerBuy60,000$1.37$82002.00
2024-12-20COMBS, ANDREWChief Chemistry OfficerBuy3,075$1.15$3536.25
2024-12-19VADDI, KRISHNADirector, CEOBuy6,888$0.89$6115.86
2024-12-19LIM, BRYANT DAVIDCLO, Interim CFO, Corp Sec.Buy25,000$0.91$22637.50
2024-12-18VADDI, KRISHNADirector, CEOBuy100,000$0.93$93210.00
2024-10-04HUANG, JANEPresident, CMOSale9,375——
2024-10-04HUANG, JANEPresident, CMOBuy9,375——
2024-10-04HUANG, JANEPresident, CMOSale3,349$2.00$6698.00
2024-07-04HUANG, JANEPresident, CMOSale9,375——
2024-07-04HUANG, JANEPresident, CMOBuy9,375——
2024-07-04HUANG, JANEPresident, CMOSale3,347$3.60$12049.20
2024-06-14SANDOR, VICTORDirectorBuy23,500——
2024-06-14FRIEDMAN, PAUL ADirectorBuy23,500——
2024-06-14DIER, MARDIDirectorBuy23,500——
2024-06-14BONITA, DAVID PDirector, 10% OwnerBuy23,500——
2024-06-14BAKER, BROS. ADVISORS LPDirector, 10% OwnerBuy23,500——
2024-06-14BABLER, MARTINDirectorBuy23,500——
2024-05-14LIM, BRYANT DAVIDCLO, Interim CFO, Corp Sec.Buy25,000——
2024-04-04HUANG, JANEPresident, CMOSale9,375——
2024-04-04HUANG, JANEPresident, CMOBuy9,375——
2024-04-04HUANG, JANEPresident, CMOSale3,347$4.74$15864.78
2024-03-01VADDI, KRISHNADirector, CEOBuy425,000——
2024-03-01SCHERLE, PEGGYChief Scientific OfficerBuy150,000——
2024-03-01LIM, BRYANT DAVIDChief Legal Officer, Corp Sec.Buy150,000——
2024-03-01HUANG, JANEPresident, CMOBuy175,000——
2024-03-01COMBS, ANDREWChief Chemistry OfficerBuy150,000——
2024-03-01CHARDONNET, LAURENTChief Financial OfficerBuy150,000——
2024-01-04HUANG, JANEPresident, CMOSale9,375——
2024-01-04HUANG, JANEPresident, CMOBuy9,375——
2024-01-04HUANG, JANEPresident, CMOSale3,844$3.77$14491.88
2023-12-13BAKER, BROS. ADVISORS LPDirector, 10% OwnerBuy7,343,307$3.15$23.13M
2023-12-13BAKER, BROS. ADVISORS LPDirector, 10% OwnerBuy593,452$3.15$1.87M
2023-10-04HUANG, JANEPresident, CMOBuy9,375——
2023-10-04HUANG, JANEPresident, CMOBuy9,375——
2023-07-04HUANG, JANEPresident, CMOSale9,375——
2023-07-04HUANG, JANEPresident, CMOBuy9,375——
2023-07-04HUANG, JANEPresident, CMOSale3,242$4.65$15075.30
2023-06-16SANDOR, VICTORDirectorBuy23,500——
2023-06-16FRIEDMAN, PAUL ADirectorBuy23,500——
2023-06-16DIER, MARDIDirectorBuy23,500——
2023-06-16BONITA, DAVID PDirector, 10% OwnerBuy23,500——
2023-06-16BAKER, BROS. ADVISORS LPDirector, 10% OwnerBuy23,500——
2023-06-16BABLER, MARTINDirectorBuy23,500——
2023-05-25VADDI, KRISHNADirector, CEOBuy900$5.31$4779.00
2023-05-24VADDI, KRISHNADirector, CEOBuy1,000$5.01$5011.40
2023-05-24LIM, BRYANT DAVIDChief Legal Officer, Corp Sec.Buy2,400$5.39$12936.00

Frequently asked questions

Are PRLD insiders buying or selling?

Over the transactions on record, PRLD insiders have been net buyers, with about $79403.18 in stock sold across 18 sales, against 27 open-market purchases.

Does insider selling at PRLD mean the stock will fall?

Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.

Which PRLD insiders are selling the most?

Recent selling is concentrated in a few names. HUANG, JANE accounts for the largest share on record, with about $79403.18 sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.